Home

PPI Platform

 

We have developed a new protein-protein interaction (PPI) small molecule inhibitor drug discovery platform.

 

Read more...

News

 

APG has received an EU grant by the PERMIDES initiative to establish an in silico drug discory platform.

 

Read more...

Pipeline

 

We have currently two drug discovery programs:

Huntington's disease and a transcription factor inhibitor for cancer treatment.

 

Read more...